Christopher_Ehinger

GE Healthcare’s Christopher Ehinger moves to Black Swan

pharmafile | October 25, 2010 | Appointment | |  Black Swan Analysis, Christopher Ehinger, GE Healthcare, appointment, sales and marketing 

Black Swan Analysis has appointed Christopher Ehinger as managing director.

He moves to the company from GE Healthcare, where he served as oncology and neurology global marketing director.

Christopher will be responsible for managing daily operations while providing new offerings in marketing and business planning. 

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content